Treatment of Keratoacanthoma with 5% Imiquimod Cream
Annals of Dermatology
;
: 14-17, 2006.
Article
in English
| WPRIM
| ID: wpr-51242
ABSTRACT
Keratoacanthoma is a rapidly growing tumor that histologically resembles squamous cell carcinoma. Surgical excision is a desirable therapeutic option, but several other treatment modalities are available. We report on two cases of keratoacanthoma that were treated with imiquimod 5% cream. Imiquimod was applied daily for the first 6 or 7 days, and then reduced to alternate days according to the tolerance and erythema severity of the patient. In both patients, the tumors fully regressed after five weeks of treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Carcinoma, Squamous Cell
/
Erythema
/
Keratoacanthoma
Limits:
Humans
Language:
English
Journal:
Annals of Dermatology
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS